keyword
https://read.qxmd.com/read/37592014/intrinsically-disordered-domain-of-transcription-factor-tcf-1-is-required-for-t-cell-developmental-fidelity
#21
JOURNAL ARTICLE
Naomi Goldman, Aditi Chandra, Isabelle Johnson, Matthew A Sullivan, Abhijeet R Patil, Ashley Vanderbeck, Atishay Jay, Yeqiao Zhou, Emily K Ferrari, Leland Mayne, Jennifer Aguilan, Hai-Hui Xue, Robert B Faryabi, E John Wherry, Simone Sidoli, Ivan Maillard, Golnaz Vahedi
In development, pioneer transcription factors access silent chromatin to reveal lineage-specific gene programs. The structured DNA-binding domains of pioneer factors have been well characterized, but whether and how intrinsically disordered regions affect chromatin and control cell fate is unclear. Here, we report that deletion of an intrinsically disordered region of the pioneer factor TCF-1 (termed L1) leads to an early developmental block in T cells. The few T cells that develop from progenitors expressing TCF-1 lacking L1 exhibit lineage infidelity distinct from the lineage diversion of TCF-1-deficient cells...
August 17, 2023: Nature Immunology
https://read.qxmd.com/read/37527035/the-pseudokinase-trib1-regulates-the-transition-of-exhausted-t%C3%A2-cells-to-a-klr-cd8-effector-state-and-its-deletion-improves-checkpoint-blockade
#22
JOURNAL ARTICLE
Susan E McClory, Oishi Bardhan, Kelly S Rome, Josephine R Giles, Amy E Baxter, Lanwei Xu, Phyllis A Gimotty, Robert B Faryabi, E John Wherry, Warren S Pear, Martha S Jordan
CD8+ T cell exhaustion (TEX ) impairs the ability of T cells to clear chronic infection or cancer. While TEX are hypofunctional, some TEX retain effector gene signatures, a feature associated with killer lectin-like receptor (KLR) expression. Although KLR+ TEX (TKLR ) may improve control of chronic antigen, the signaling molecules regulating this population are poorly understood. Using single-cell RNA sequencing (scRNA-seq), flow cytometry, RNA velocity, and single-cell T cell receptor sequencing (scTCR-seq), we demonstrate that deleting the pseudokinase Trib1 shifts TEX toward CX3CR1+ intermediates with robust enrichment of TKLR via clonal T cell expansion...
July 31, 2023: Cell Reports
https://read.qxmd.com/read/37398323/deep-phenotyping-of-the-lipidomic-response-in-covid-and-non-covid-sepsis
#23
Hu Meng, Arjun Sengupta, Emanuela Ricciotti, Antonijo Mrčela, Divij Mathew, Liudmila L Mazaleuskaya, Soumita Ghosh, Thomas G Brooks, Alexandra P Turner, Alessa Soares Schanoski, Nicholas F Lahens, Ai Wen Tan, Ashley Woolfork, Greg Grant, Katalin Susztak, Andrew G Letizia, Stuart C Sealfon, E John Wherry, Krzysztof Laudanski, Aalim M Weljie, Nuala B Meyer, Garret A FitzGerald
Lipids may influence cellular penetrance by pathogens and the immune response that they evoke. Here we find a broad based lipidomic storm driven predominantly by secretory (s) phospholipase A 2 (sPLA 2 ) dependent eicosanoid production occurs in patients with sepsis of viral and bacterial origin and relates to disease severity in COVID-19. Elevations in the cyclooxygenase (COX) products of arachidonic acid (AA), PGD 2 and PGI 2 , and the AA lipoxygenase (LOX) product, 12-HETE, and a reduction in the high abundance lipids, ChoE 18:3, LPC-O-16:0 and PC-O-30:0 exhibit relative specificity for COVID-19 amongst such patients, correlate with the inflammatory response and link to disease severity...
June 2, 2023: bioRxiv
https://read.qxmd.com/read/37377890/phase-i-trial-of-autologous-rna-electroporated-cmet-directed-car-t-cells-administered-intravenously-in-patients-with-melanoma-and-breast-carcinoma
#24
JOURNAL ARTICLE
Payal D Shah, Alexander C Huang, Xiaowei Xu, Robert Orlowski, Ravi K Amaravadi, Lynn M Schuchter, Paul Zhang, Julia Tchou, Tina Matlawski, Amanda Cervini, Joanne Shea, Joan Gilmore, Lester Lledo, Karen Dengel, Amy Marshall, E John Wherry, Gerald P Linette, Andrea Brennan, Vanessa Gonzalez, Irina Kulikovskaya, Simon F Lacey, Gabriela Plesa, Carl H June, Robert H Vonderheide, Tara C Mitchell
PURPOSE: Treatments are limited for metastatic melanoma and metastatic triple-negative breast cancer (mTNBC). This pilot phase I trial (NCT03060356) examined the safety and feasibility of intravenous RNA-electroporated chimeric antigen receptor (CAR) T cells targeting the cell-surface antigen cMET. EXPERIMENTAL DESIGN: Metastatic melanoma or mTNBC subjects had at least 30% tumor expression of cMET, measurable disease and progression on prior therapy. Patients received up to six infusions (1 × 10e8 T cells/dose) of CAR T cells without lymphodepleting chemotherapy...
May 2023: Cancer Res Commun
https://read.qxmd.com/read/37315535/the-swi-snf-chromatin-remodeling-complexes-baf-and-pbaf-differentially-regulate-epigenetic-transitions-in-exhausted-cd8-t%C3%A2-cells
#25
JOURNAL ARTICLE
Amy E Baxter, Hua Huang, Josephine R Giles, Zeyu Chen, Jennifer E Wu, Sydney Drury, Katherine Dalton, Simone L Park, Leonel Torres, Brandon W Simone, Max Klapholz, Shin Foong Ngiow, Elizabeth Freilich, Sasikanth Manne, Victor Alcalde, Viktoriya Ekshyyan, Shelley L Berger, Junwei Shi, Martha S Jordan, E John Wherry
CD8+ T cell exhaustion (Tex) limits disease control during chronic viral infections and cancer. Here, we investigated the epigenetic factors mediating major chromatin-remodeling events in Tex-cell development. A protein-domain-focused in vivo CRISPR screen identified distinct functions for two versions of the SWI/SNF chromatin-remodeling complex in Tex-cell differentiation. Depletion of the canonical SWI/SNF form, BAF, impaired initial CD8+ T cell responses in acute and chronic infection. In contrast, disruption of PBAF enhanced Tex-cell proliferation and survival...
June 13, 2023: Immunity
https://read.qxmd.com/read/37236193/the-enteric-nervous-system-relays-psychological-stress-to-intestinal-inflammation
#26
JOURNAL ARTICLE
Kai Markus Schneider, Niklas Blank, Yelina Alvarez, Katharina Thum, Patrick Lundgren, Lev Litichevskiy, Madeleine Sleeman, Klaas Bahnsen, Jihee Kim, Simon Kardo, Shaan Patel, Lenka Dohnalová, Giulia T Uhr, Hélène C Descamps, Susanna Kircher, Alana M McSween, Ashkan Rezazadeh Ardabili, Kelsey M Nemec, Monica T Jimenez, Lila G Glotfelty, Joshua D Eisenberg, Emma E Furth, Jorge Henao-Mejia, F Chris Bennett, Marie J Pierik, Mariëlle Romberg-Camps, Zlatan Mujagic, Marco Prinz, Carolin V Schneider, E John Wherry, Meenakshi Bewtra, Robert O Heuckeroth, Maayan Levy, Christoph A Thaiss
Mental health profoundly impacts inflammatory responses in the body. This is particularly apparent in inflammatory bowel disease (IBD), in which psychological stress is associated with exacerbated disease flares. Here, we discover a critical role for the enteric nervous system (ENS) in mediating the aggravating effect of chronic stress on intestinal inflammation. We find that chronically elevated levels of glucocorticoids drive the generation of an inflammatory subset of enteric glia that promotes monocyte- and TNF-mediated inflammation via CSF1...
June 22, 2023: Cell
https://read.qxmd.com/read/37215021/signal-recovery-in-single-cell-batch-integration
#27
Zhaojun Zhang, Divij Mathew, Tristan Lim, Sijia Huang, E John Wherry, Andy J Minn, Zongming Ma, Nancy R Zhang
Data integration to align cells across batches has become a cornerstone of most single cell data analysis pipelines, critically affecting downstream analyses. Yet, when the batches are expected to biologically differ, how much signal is erased during integration? Currently, there are no guidelines for when the biological differences between samples are separable from batch effects, and thus, data integration usually involve a lot of guesswork: Cells across batches should be aligned to be "appropriately" mixed, while preserving "main cell type clusters"...
May 9, 2023: bioRxiv
https://read.qxmd.com/read/37159385/high-throughput-interrogation-of-immune-responses-using-the-human-immune-profiling-pipeline
#28
JOURNAL ARTICLE
Guanning Wang, Olga Lyudovyk, Justin Y Kim, Ya-Hui Lin, Yuval Elhanati, Divij Mathew, E John Wherry, Ramin S Herati, Allison R Greenplate, Benjamin Greenbaum, Santosha A Vardhana, Alexander C Huang
The current abundance of immunotherapy clinical trials presents an opportunity to learn about the underlying mechanisms and pharmacodynamic effects of novel drugs on the human immune system. Here, we present a protocol to study how these immune responses impact clinical outcomes using large-scale high-throughput immune profiling of clinical cohorts. We describe the Human Immune Profiling Pipeline, which comprises an end-to-end solution from flow cytometry results to computational approaches and unsupervised patient clustering based on lymphocyte landscape...
May 8, 2023: STAR protocols
https://read.qxmd.com/read/37131713/-in-vitro-modeling-of-cd8-t-cell-exhaustion-enables-crispr-screening-to-reveal-a-role-for-bhlhe40
#29
Jennifer E Wu, Sasikanth Manne, Shin Foong Ngiow, Amy E Baxter, Hua Huang, Elizabeth Freilich, Megan L Clark, Joanna H Lee, Zeyu Chen, Omar Khan, Ryan P Staupe, Yinghui J Huang, Junwei Shi, Josephine R Giles, E John Wherry
Identifying novel molecular mechanisms of exhausted CD8 T cells (T ex ) is a key goal of improving immunotherapy of cancer and other diseases. However, high-throughput interrogation of in vivo T ex can be costly and inefficient. In vitro models of T ex are easily customizable and quickly generate high cellular yield, offering an opportunity to perform CRISPR screening and other high-throughput assays. We established an in vitro model of chronic stimulation and benchmarked key phenotypic, functional, transcriptional, and epigenetic features against bona fide in vivo T ex ...
April 17, 2023: bioRxiv
https://read.qxmd.com/read/37095348/efficient-engineering-of-human-and-mouse-primary-cells-using-peptide-assisted-genome-editing
#30
JOURNAL ARTICLE
Zhen Zhang, Amy E Baxter, Diqiu Ren, Kunhua Qin, Zeyu Chen, Sierra M Collins, Hua Huang, Chad A Komar, Peter F Bailer, Jared B Parker, Gerd A Blobel, Rahul M Kohli, E John Wherry, Shelley L Berger, Junwei Shi
Simple, efficient and well-tolerated delivery of CRISPR genome editing systems into primary cells remains a major challenge. Here we describe an engineered Peptide-Assisted Genome Editing (PAGE) CRISPR-Cas system for rapid and robust editing of primary cells with minimal toxicity. The PAGE system requires only a 30-min incubation with a cell-penetrating Cas9 or Cas12a and a cell-penetrating endosomal escape peptide to achieve robust single and multiplex genome editing. Unlike electroporation-based methods, PAGE gene editing has low cellular toxicity and shows no significant transcriptional perturbation...
April 24, 2023: Nature Biotechnology
https://read.qxmd.com/read/37027481/human-t-follicular-helper-clones-seed-the-germinal-center-resident-regulatory-pool
#31
JOURNAL ARTICLE
Carole Le Coz, Derek A Oldridge, Ramin S Herati, Nina De Luna, James Garifallou, Emylette Cruz Cabrera, Jonathan P Belman, Dana Pueschl, Luisa V Silva, Ainsley V C Knox, Whitney Reid, Samuel Yoon, Karen B Zur, Steven D Handler, Hakon Hakonarson, E John Wherry, Michael Gonzalez, Neil Romberg
The mechanisms by which FOXP3+ T follicular regulatory (Tfr) cells simultaneously steer antibody formation toward microbe or vaccine recognition and away from self-reactivity remain incompletely understood. To explore underappreciated heterogeneity in human Tfr cell development, function, and localization, we used paired TCRVA / TCRVB sequencing to distinguish tonsillar Tfr cells that are clonally related to natural regulatory T cells (nTfr) from those likely induced from T follicular helper (Tfh) cells (iTfr)...
April 14, 2023: Science Immunology
https://read.qxmd.com/read/36824931/the-pseudokinase-trib1-regulates-the-transition-of-exhausted-t-cells-to-a-klr-cd8-effector-state-and-its-deletion-improves-checkpoint-blockade
#32
Susan E McClory, Oishi Bardhan, Kelly S Rome, Josephine R Giles, Amy E Baxter, Lanwei Xu, Phyllis A Gimotty, Robert B Faryabi, E John Wherry, Warren S Pear, Martha S Jordan
T cell exhaustion (T EX ) impairs the ability of T cells to clear chronic infection or cancer. While exhausted T cells are hypofunctional, some exhausted T cells retain effector gene signatures, a feature that is associated with expression of KLRs (killer lectin-like receptors). Although KLR + T cells may improve control of chronic antigen, the signaling molecules regulating this population are poorly understood. Using scRNA-seq, flow cytometry, RNA velocity, and scTCR-seq, we demonstrate that deleting the pseudokinase Trib1 shifts T EX towards CX3CR1 + intermediates (T INT ) with robust enrichment of KLR + CD8 + T cells (T KLR ) via clonal T cell expansion...
February 16, 2023: bioRxiv
https://read.qxmd.com/read/36816182/stage-of-infection-with-mycobacterium-avium-subsp-paratuberculosis-impacts-expression-of-rab5-rab7-and-cyp27b1-in-macrophages-within-the-ileum-of-naturally-infected-cows
#33
JOURNAL ARTICLE
Taylor L T Wherry, Mark Heggen, Adrienne L Shircliff, Shankumar Mooyottu, Judith R Stabel
INTRODUCTION: Macrophages are the preferential target of Mycobacterium avium subsp. paratuberculosis (MAP), the etiologic agent of ruminant paratuberculosis. Uptake of pathogens by intestinal macrophages results in their trafficking through endosomal compartments, ultimately leading to fusion with an acidic lysosome to destroy the pathogen. MAP possesses virulence factors which disrupt these endosomal pathways. Additionally, levels of serum vitamin D3 have proven relevant to host immunity...
2023: Frontiers in Veterinary Science
https://read.qxmd.com/read/36798171/prior-vaccination-enhances-immune-responses-during-sars-cov-2-breakthrough-infection-with-early-activation-of-memory-t-cells-followed-by-production-of-potent-neutralizing-antibodies
#34
Mark M Painter, Timothy S Johnston, Kendall A Lundgreen, Jefferson J S Santos, Juliana S Qin, Rishi R Goel, Sokratis A Apostolidis, Divij Mathew, Bria Fulmer, Justine C Williams, Michelle L McKeague, Ajinkya Pattekar, Ahmad Goode, Sean Nasta, Amy E Baxter, Josephine R Giles, Ashwin N Skelly, Laura E Felley, Maura McLaughlin, Joellen Weaver, Oliva Kuthuru, Jeanette Dougherty, Sharon Adamski, Sherea Long, Macy Kee, Cynthia Clendenin, Ricardo da Silva Antunes, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Alexander C Huang, Daniel J Rader, Scott E Hensley, Paul Bates, Allison R Greenplate, E John Wherry
SARS-CoV-2 infection of vaccinated individuals is increasingly common but rarely results in severe disease, likely due to the enhanced potency and accelerated kinetics of memory immune responses. However, there have been few opportunities to rigorously study early recall responses during human viral infection. To better understand human immune memory and identify potential mediators of lasting vaccine efficacy, we used high-dimensional flow cytometry and SARS-CoV-2 antigen probes to examine immune responses in longitudinal samples from vaccinated individuals infected during the Omicron wave...
February 6, 2023: bioRxiv
https://read.qxmd.com/read/36646856/cancer-cells-resistant-to-immune-checkpoint-blockade-acquire-interferon-associated-epigenetic-memory-to-sustain-t-cell-dysfunction
#35
JOURNAL ARTICLE
Jingya Qiu, Bihui Xu, Darwin Ye, Diqiu Ren, Shangshang Wang, Joseph L Benci, Yuanming Xu, Hemant Ishwaran, Jean-Christophe Beltra, E John Wherry, Junwei Shi, Andy J Minn
Prolonged interferon (IFN) signaling in cancer cells can promote resistance to immune checkpoint blockade (ICB). How cancer cells retain effects of prolonged IFN stimulation to coordinate resistance is unclear. We show that, across human and/or mouse tumors, immune dysfunction is associated with cancer cells acquiring epigenetic features of inflammatory memory. Here, inflammatory memory domains, many of which are initiated by chronic IFN-γ, are maintained by signal transducer and activator of transcription (STAT)1 and IFN regulatory factor (IRF)3 and link histone 3 lysine 4 monomethylation (H3K4me1)-marked chromatin accessibility to increased expression of a subset of IFN-stimulated genes (ISGs)...
January 2023: Nature Cancer
https://read.qxmd.com/read/36594081/extended-sars-cov-2-mrna-vaccine-prime-boost-intervals-enhances-b-cell-immunity-with-limited-impact-on-t-cells
#36
JOURNAL ARTICLE
Alexandre Nicolas, Gérémy Sannier, Mathieu Dubé, Manon Nayrac, Alexandra Tauzin, Mark M Painter, Rishi R Goel, Mélanie Laporte, Gabrielle Gendron-Lepage, Halima Medjahed, Justine C Williams, Nathalie Brassard, Julia Niessl, Laurie Gokool, Chantal Morrisseau, Pascale Arlotto, Cécile Tremblay, Valérie Martel-Laferrière, Andrés Finzi, Allison R Greenplate, E John Wherry, Daniel E Kaufmann
Spacing the first two doses of SARS-CoV-2 mRNA vaccines beyond 3-4 weeks raised initial concerns about vaccine efficacy. While studies have since shown that long-interval regimens induce robust antibody responses, their impact on B and T cell immunity is poorly known. Here, we compare in SARS-CoV-2 naïve donors B and T cell responses to two mRNA vaccine doses administered 3-4 versus 16 weeks apart. After boost, the longer interval results in higher magnitude and a more mature phenotype of RBD-specific B cells...
December 29, 2022: IScience
https://read.qxmd.com/read/36479446/validating-a-proteomic-signature-of-severe-covid-19
#37
JOURNAL ARTICLE
Christopher V Cosgriff, Todd A Miano, Divij Mathew, Alexander C Huang, Heather M Giannini, Leticia Kuri-Cervantes, M Betina Pampena, Caroline A G Ittner, Ariel R Weisman, Roseline S Agyekum, Thomas G Dunn, Oluwatosin Oniyide, Alexandra P Turner, Kurt D'Andrea, Sharon Adamski, Allison R Greenplate, Brian J Anderson, Michael O Harhay, Tiffanie K Jones, John P Reilly, Nilam S Mangalmurti, Michael G S Shashaty, Michael R Betts, E John Wherry, Nuala J Meyer
UNLABELLED: COVID-19 is a heterogenous disease. Biomarker-based approaches may identify patients at risk for severe disease, who may be more likely to benefit from specific therapies. Our objective was to identify and validate a plasma protein signature for severe COVID-19. DESIGN: Prospective observational cohort study. SETTING: Two hospitals in the United States. PATIENTS: One hundred sixty-seven hospitalized adults with COVID-19...
December 2022: Critical care explorations
https://read.qxmd.com/read/36477542/author-correction-decade-long-leukaemia-remissions-with-persistence-of-cd4-car-t-cells
#38
J Joseph Melenhorst, Gregory M Chen, Meng Wang, David L Porter, Changya Chen, McKensie A Collins, Peng Gao, Shovik Bandyopadhyay, Hongxing Sun, Ziran Zhao, Stefan Lundh, Iulian Pruteanu-Malinici, Christopher L Nobles, Sayantan Maji, Noelle V Frey, Saar I Gill, Alison W Loren, Lifeng Tian, Irina Kulikovskaya, Minnal Gupta, David E Ambrose, Megan M Davis, Joseph A Fraietta, Jennifer L Brogdon, Regina M Young, Anne Chew, Bruce L Levine, Donald L Siegel, Cécile Alanio, E John Wherry, Frederic D Bushman, Simon F Lacey, Kai Tan, Carl H June
No abstract text is available yet for this article.
December 7, 2022: Nature
https://read.qxmd.com/read/36289450/divergent-clonal-differentiation-trajectories-of-t-cell-exhaustion
#39
JOURNAL ARTICLE
Bence Daniel, Kathryn E Yost, Sunnie Hsiung, Katalin Sandor, Yu Xia, Yanyan Qi, Kamir J Hiam-Galvez, Mollie Black, Colin J Raposo, Quanming Shi, Stefanie L Meier, Julia A Belk, Josephine R Giles, E John Wherry, Howard Y Chang, Takeshi Egawa, Ansuman T Satpathy
Chronic antigen exposure during viral infection or cancer promotes an exhausted T cell (Tex) state with reduced effector function. However, whether all antigen-specific T cell clones follow the same Tex differentiation trajectory remains unclear. Here, we generate a single-cell multiomic atlas of T cell exhaustion in murine chronic viral infection that redefines Tex phenotypic diversity, including two late-stage Tex subsets with either a terminal exhaustion (Texterm ) or a killer cell lectin-like receptor-expressing cytotoxic (TexKLR ) phenotype...
November 2022: Nature Immunology
https://read.qxmd.com/read/36278493/ppt1-inhibition-enhances-the-antitumor-activity-of-anti-pd-1-antibody-in-melanoma
#40
JOURNAL ARTICLE
Gaurav Sharma, Rani Ojha, Estela Noguera-Ortega, Vito W Rebecca, John Attanasio, Shujing Liu, Shengfu Piao, Jennifer J Lee, Michael C Nicastri, Sandra L Harper, Amruta Ronghe, Vaibhav Jain, Jeffrey D Winkler, David W Speicher, Jerome Mastio, Phyllis A Gimotty, Xiaowei Xu, E John Wherry, Dmitry I Gabrilovich, Ravi K Amaravadi
No abstract text is available yet for this article.
October 24, 2022: JCI Insight
keyword
keyword
78313
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.